Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00085020
Status:
COMPLETED
Last Update Posted:
2020-08-03
First Post:
2004-06-10
Brief Title:
GW572016 and Trastuzumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2Neu
Sponsor:
Jonsson Comprehensive Cancer Center
Organization:
Jonsson Comprehensive Cancer Center
Organization Data
Organization:
Jonsson Comprehensive Cancer Center
Class:
OTHER
Study ID:
CDR0000367118
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Jonsson Comprehensive Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| GlaxoSmithKline | INDUSTRY |